Literature DB >> 25664518

Experiences of stigma among hepatitis B and C patients in Rawalpindi and Islamabad, Pakistan.

I Rafique1, M A N Saqib1, S Siddiqui2, M A Munir1, H Qureshi1, N Javed1, S Naz1, I Z Tirmazi3.   

Abstract

Hepatitis B and C are chronic diseases with mental and social impacts which can result in poor quality of life. The aim of this study was to determine the experiences of stigma in a sample of hepatitis B- and C-positive patients in Pakistan. In a cross-sectional study, 140 inpatients and outpatients from 3 tertiary-care hospitals in Islamabad and Rawalpindi answered a semi-structured questionnaire about stigma experienced from relatives, friends, spouse and health-care providers, and about work/financial problems. The majority of patients (75%) said they had had to change their lifestyle, and significantly more were males than females. Stigma was marked in terms of disease transmission, with 66% of patients fearing that they could transmit the infection to others; 19% said that family members avoided sharing towels, soap and eating and drinking utensils. Marital relationships were affected for 51% of married patients who had told their spouse. Patients' comments showed a sense of family and societal discrimination resulting in feelings of disappointment and isolation.

Entities:  

Mesh:

Year:  2015        PMID: 25664518

Source DB:  PubMed          Journal:  East Mediterr Health J        ISSN: 1020-3397            Impact factor:   1.628


  10 in total

1.  Psychiatric Morbidity, Fatigue, Stigma and Quality of Life of Patients With Hepatitis B Infection.

Authors:  Rajesh Gupta; Ajit Avasthi; Yogesh K Chawla; Sandeep Grover
Journal:  J Clin Exp Hepatol       Date:  2020-04-13

2.  Hepatitis B Infection: A Mixed Methods of Disclosure Pattern and Social Problems in the Nigerian Family.

Authors:  Olusegun Adekanle; Akinwumi Oluwole Komolafe; Samuel A Olowookere; Oluwasegun Ijarotimi; Dennis Amajuoyi Ndububa
Journal:  J Patient Exp       Date:  2019-03-07

3.  A qualitative study on individual experiences of chronic hepatitis B patients.

Authors:  Zahra Taheri Ezbarami; Parkhideh Hassani; Mansoureh Zagheri Tafreshi; Hamid Alavi Majd
Journal:  Nurs Open       Date:  2017-10-23

4.  The Urgency to Mitigate the Spread of Hepatitis C in Pakistan Through Blood Transfusion Reform.

Authors:  Kamiar Alaei; Mohammad Sarwar; Arash Alaei
Journal:  Int J Health Policy Manag       Date:  2018-03-01

5.  Premarital hepatitis screening. Attitude towards screening and the risk factors for transmission.

Authors:  Ibtehaj M Alharbi; Badr M Aljarallah
Journal:  Saudi Med J       Date:  2018-12       Impact factor: 1.484

6.  Stigma among healthcare workers towards hepatitis B infection in Bangalore, India: a qualitative study.

Authors:  F C van der Scheun; M C M Nagelkerke; A Kilaru; V Shridhar; R Prasad; T S van der Werf
Journal:  BMC Health Serv Res       Date:  2019-10-22       Impact factor: 2.655

7.  Beyond the diagnosis: a qualitative exploration of the experiences of persons with hepatitis B in the Accra Metropolis, Ghana.

Authors:  Charles Ampong Adjei; Florence Naab; Ernestina S Donkor
Journal:  BMJ Open       Date:  2017-11-03       Impact factor: 2.692

8.  The experience of discrimination of individuals living with chronic hepatitis B in four provinces of China.

Authors:  Bingfeng Han; Qianli Yuan; Yuhui Shi; Lai Wei; Jinlin Hou; Jia Shang; Ying Han; Cunduo Jin; Po-Lin Chan; Hui Zhuang; Jie Li; Fuqiang Cui
Journal:  PLoS One       Date:  2018-04-12       Impact factor: 3.240

9.  A blind spot? Confronting the stigma of hepatitis B virus (HBV) infection - A systematic review.

Authors:  Jolynne Mokaya; Anna L McNaughton; Lela Burbridge; Tongai Maponga; Geraldine O'Hara; Monique Andersson; Janet Seeley; Philippa C Matthews
Journal:  Wellcome Open Res       Date:  2018-08-21

10.  Illness perception about hepatitis C virus infection: a cross-sectional study from Khyber Pakhtunkhwa Pakistan.

Authors:  Shahan Ullah; Salamat Ali; Muhammad Daud; Vibhu Paudyal; Kawsar Hayat; Syed Muhammad Hamid; Tofeeq Ur-Rehman
Journal:  BMC Infect Dis       Date:  2022-01-21       Impact factor: 3.090

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.